
Opinion|Videos|March 11, 2024
Step-Up Dosing of Bispecifics in the Outpatient Setting for Patients with Multiple Myeloma
Michael Singel, PharmD; and Carol Ann Huff, MD, discuss how step-up dosing for bispecific antibodies has been implemented in the outpatient setting with monitoring considerations for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome to ensure patient safety.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Men Face Higher Odds of Later-Stage Diagnosis Across 20 Cancer Types
2
Investigational mRNA Flu Vaccine Broadens Antibody Defenses, Sustains Immune "Training Hub" Longer Than Standard Shot
3
FDA Accepts NDA for AD109 to Treat of Adults With Obstructive Sleep Apnea
4
FDA Approves Enlicitide, the First Oral PCSK9 Inhibitor for High Cholesterol
5







































































































